Berenice Fernández-Rojas
Berenice Fernández-Rojas has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Jesús Hernández-Juárez
Secretaría de Ciencia, Investigación, Humanidades, Tecnología e Innovación-Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional Unidad Oaxaca, Instituto Politécnico Nacional, Santa Cruz Xoxocotlán 71233, Oaxaca, Mexico
4 shared publications José Pedraza-Chaverri
Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Circuito interior s/n, Ciudad Universitaria, 04510, Ciudad de México, México
3 shared publications- José Pedraza-Chaverri
Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, 04510, Ciudad de México, México
3 shared publications Omar Noel Medina-Campos
Department of Biology, Faculty of Chemistry, National Autonomous University of Mexico (UNAM), University City, Mexico
3 shared publications- Rogelio Hernández-Pando
Experimental Pathology Department, Instituto Nacional de Ciencia Médicas y Nutrición “Salvador Zubirán”, Mexico City 14080, Mexico
3 shared publications - Abimael López-Pérez
Instituto Politécnico Nacional
2 shared publications
Latest Publications
- Open Access
- 1 July 2025
- Published by Botanical Sciences, Sociedad Botanica de Mexico, AC in Botanical Sciences
- Vol. 103 (3) , 644-657
The hydroethanolic extract of leaves of Laelia furfuracea inhibits blood coagulation and platelet aggregation
Background: Laelia furfuracea is an orchid with anticoagulant properties; however, it is unknown which coagulation factors are inhibited and whether the plant has antiplatelet activity. Questions: Does the hydroethanolic extract of leaves of L. furfuracea inhibit coagulation factor activity and platelet aggregation? Studied species: Laelia furfuracea. Study site and dates: Plant material was collected in April 2023 in Santo Domingo Yanhuitlán, Oaxaca, Mexico. Methods: The anticoagulant and antiplatelet effects of the extracts of L. furfuracea were evaluated in samples from patients with thrombosis through coagulometric assays and light transmission aggregometry. Results: The extract of L. furfuracea inhibited the activity of factors II, V, VIII, and XI in a concentration-dependent manner. The highest extract concentration, 14.0 mg/mL, inhibited about 60 % of factors II and V activity, but ˃ 95 % of factors VIII and XI. Moreover, at a 1.0 mg/mL concentration, the extract inhibited platelet aggregation induced by ADP, thrombin, and epinephrine in 85, 97, and 83 %, respectively. Conclusions: It was demonstrated that the orchid extract inhibits both the activity of factors II, V, VIII, XI, and thrombin-, ADP-, and epinephrine-induced platelet aggregation. Polyphenols stand out among the possible bioactive compounds of the orchid with anticoagulant and/or antiplatelet activity.
- 1 July 2025
- Published by Botanical Sciences, Sociedad Botanica de Mexico, AC in Botanical Sciences
- Vol. 103 (3) , 644-657
Open AccessThe hydroethanolic extract of leaves of Laelia furfuracea inhibits blood coagulation and platelet aggregation
Background: Laelia furfuracea is an orchid with anticoagulant properties; however, it is unknown which coagulation factors are inhibited and whether the plant has antiplatelet activity. Questions: Does the hydroethanolic extract of leaves of L. furfuracea inhibit coagulation factor activity and platelet aggregation? Studied species: Laelia furfuracea. Study site and dates: Plant material was collected in April 2023 in Santo Domingo Yanhuitlán, Oaxaca, Mexico. Methods: The anticoagulant and antiplatelet effects of the extracts of L. furfuracea were evaluated in samples from patients with thrombosis through coagulometric assays and light transmission aggregometry. Results: The extract of L. furfuracea inhibited the activity of factors II, V, VIII, and XI in a concentration-dependent manner. The highest extract concentration, 14.0 mg/mL, inhibited about 60 % of factors II and V activity, but ˃ 95 % of factors VIII and XI. Moreover, at a 1.0 mg/mL concentration, the extract inhibited platelet aggregation induced by ADP, thrombin, and epinephrine in 85, 97, and 83 %, respectively. Conclusions: It was demonstrated that the orchid extract inhibits both the activity of factors II, V, VIII, XI, and thrombin-, ADP-, and epinephrine-induced platelet aggregation. Polyphenols stand out among the possible bioactive compounds of the orchid with anticoagulant and/or antiplatelet activity.
- Open Access
Antiplatelet, Anticoagulant, and Fibrinolytic Activity of Orchids: A Review
Thrombosis is the occlusion of a blood vessel and is responsible for the highest number of deaths worldwide. Its treatment comprises the use of anticoagulants, antiplatelets, and thrombolytics. Although many antithrombotic drugs are currently available, none is completely effective and safe. Plants are a valuable source of compounds with antithrombotic properties. Some orchid species have been used in traditional medicine for their antithrombotic properties. This review informs about the contribution of orchids in this field and the studies that have validated their properties.
Open AccessAntiplatelet, Anticoagulant, and Fibrinolytic Activity of Orchids: A Review
Thrombosis is the occlusion of a blood vessel and is responsible for the highest number of deaths worldwide. Its treatment comprises the use of anticoagulants, antiplatelets, and thrombolytics. Although many antithrombotic drugs are currently available, none is completely effective and safe. Plants are a valuable source of compounds with antithrombotic properties. Some orchid species have been used in traditional medicine for their antithrombotic properties. This review informs about the contribution of orchids in this field and the studies that have validated their properties.
- Open Access
- 22 September 2023
- Published by Elsevier in Current Research in Toxicology
- Vol. 5, 100128
Antioxidant activity of glucosamine and its effects on ROS production, Nrf2, and O-GlcNAc expression in HMEC-1 cells
- 22 September 2023
- Published by Elsevier in Current Research in Toxicology
- Vol. 5, 100128
Open AccessAntioxidant activity of glucosamine and its effects on ROS production, Nrf2, and O-GlcNAc expression in HMEC-1 cells
- Open Access
- 30 April 2023
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 69 (4) , 46-52
Glucosamine effects on platelet aggregation of type 2 diabetes mellitus patients: in vitro assays
Hyperglycemia, insulin resistance, and endothelium dysfunction are related to platelet hyperactivity in type 2 diabetes mellitus (T2D) patients. Glucosamine (GlcN) has inhibitory effects on platelets of animals and healthy donors, but this role in platelets from T2D patients is unknown. The aim of this study was to evaluate the GlcN in vitro effects on platelet aggregation in T2D patients and healthy donors. Donors´ and T2D patients' samples were analyzed through flow cytometry, Western blot, and platelet aggregometry. Platelet aggregation was induced using ADP and thrombin, with or without GlcN, N-Acetyl-glucosamine, galactose, or fucose. GlcN inhibited ADP and thrombin-induced platelet aggregation, while the other carbohydrates did not. GlcN suppressed the second wave of ADP-induced platelet aggregation. No differences in the percent of inhibition of ADP-induced platelet aggregation by GlcN were found between donors and T2D patients, but this effect was significantly higher in healthy donors using thrombin as an agonist. In addition, GlcN increased protein O-GlcNAcylation (O-GlcNAc) in the platelets from T2D patients but not in healthy donors. In conclusion, GlcN inhibited the platelet aggregation induced by ADP and thrombin for both study groups and increased O-GlcNAc in platelets from T2D patients. Further studies are required to evaluate the possible use of GlcN as an antiplatelet agent.
- 30 April 2023
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 69 (4) , 46-52
Open AccessGlucosamine effects on platelet aggregation of type 2 diabetes mellitus patients: in vitro assays
Hyperglycemia, insulin resistance, and endothelium dysfunction are related to platelet hyperactivity in type 2 diabetes mellitus (T2D) patients. Glucosamine (GlcN) has inhibitory effects on platelets of animals and healthy donors, but this role in platelets from T2D patients is unknown. The aim of this study was to evaluate the GlcN in vitro effects on platelet aggregation in T2D patients and healthy donors. Donors´ and T2D patients' samples were analyzed through flow cytometry, Western blot, and platelet aggregometry. Platelet aggregation was induced using ADP and thrombin, with or without GlcN, N-Acetyl-glucosamine, galactose, or fucose. GlcN inhibited ADP and thrombin-induced platelet aggregation, while the other carbohydrates did not. GlcN suppressed the second wave of ADP-induced platelet aggregation. No differences in the percent of inhibition of ADP-induced platelet aggregation by GlcN were found between donors and T2D patients, but this effect was significantly higher in healthy donors using thrombin as an agonist. In addition, GlcN increased protein O-GlcNAcylation (O-GlcNAc) in the platelets from T2D patients but not in healthy donors. In conclusion, GlcN inhibited the platelet aggregation induced by ADP and thrombin for both study groups and increased O-GlcNAc in platelets from T2D patients. Further studies are required to evaluate the possible use of GlcN as an antiplatelet agent.
- Open Access
- 14 May 2022
- Published by Universidad Autónoma "Benito Juárez" de Oaxaca in Tequio
- Vol. 5 (15) , 31-40
La expresión de 8-hidroxi 2’-desoxiguanosina en el cáncer
The production of reactive oxygen species (ROS) takes place in all organisms. ROS regulate the cell cycle and other biological phenomena that make them essential for life. However, when there is a ROS excess and/or the antioxidant system is reduced, oxidative stress is induced. During this process, ROS can attack various biomolecules and generate oxidative damage. The hydroxyl radical is a highly reactive ROS that can react with guanine in deoxyribonucleic acid (DNA), generating the molecule 8-hydroxy-2’-deoxyguanosine (8-OHdG), a marker of oxidative damage to DNA. Some research have shown that cancer patients or mouse models of cancer have elevated levels of 8-OHdG in serum, urine, saliva, and tissues. This literature review summarizes the main findings of 8-OHdG in several types of cancer and shows the evidence for the potential use of 8-OHdG as a biomarker of oxidative DNA damage in cancer.
- 14 May 2022
- Published by Universidad Autónoma "Benito Juárez" de Oaxaca in Tequio
- Vol. 5 (15) , 31-40
Open AccessLa expresión de 8-hidroxi 2’-desoxiguanosina en el cáncer
The production of reactive oxygen species (ROS) takes place in all organisms. ROS regulate the cell cycle and other biological phenomena that make them essential for life. However, when there is a ROS excess and/or the antioxidant system is reduced, oxidative stress is induced. During this process, ROS can attack various biomolecules and generate oxidative damage. The hydroxyl radical is a highly reactive ROS that can react with guanine in deoxyribonucleic acid (DNA), generating the molecule 8-hydroxy-2’-deoxyguanosine (8-OHdG), a marker of oxidative damage to DNA. Some research have shown that cancer patients or mouse models of cancer have elevated levels of 8-OHdG in serum, urine, saliva, and tissues. This literature review summarizes the main findings of 8-OHdG in several types of cancer and shows the evidence for the potential use of 8-OHdG as a biomarker of oxidative DNA damage in cancer.
- Open Access
- 1 January 2020
- Published by Elsevier in Toxicology Reports
- Vol. 7, 101-108
Lipoteichoic acid reduces antioxidant enzymes in H9c2 cells
- 1 January 2020
- Published by Elsevier in Toxicology Reports
- Vol. 7, 101-108
Open AccessLipoteichoic acid reduces antioxidant enzymes in H9c2 cells
- Open Access
- 4 September 2017
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 22 (1) , 19
Luteolin, quercetin, genistein and quercetagetin inhibit the effects of lipopolysaccharide obtained from Porphyromonas gingivalis in H9c2 cardiomyoblasts
One of the microorganisms from dental plaque associated with severe inflammatory responses in infectious endocarditis is Porphyromonas gingivalis. It is a Gram-negative bacteria harvested from chronic periodontitis patients. Lipopolysaccharide (LPS) obtained from P. gingivalis promotes the expressions of interleukin-1 (IL-1), IL-6 and tumor necrosis factor alpha (TNF-α). Flavonoids are thought to participate in processes that control inflammation, such as the expression of cyclooxygenase-2 (COX-2). We investigated the effects of luteolin, quercetin, genistein and quercetagetin on cardiomyoblasts treated with LPS alone or in combination with following inhibitors p38 (SB203580), ERK (PD98059), JNK (SP600125) and PKC (Calphostin C) for 1 h. The kinase activation and COX-2 expression levels were determined at the gene and protein levels. These flavonoids are considered to inhibit the activation of mitogen-activated protein kinase (MAPK) and the degradation of inhibitor of kappa B-alpha (IκB-α). They also play a role in COX-2 expression. We conclude that the tested flavonoids inhibit inflammatory responses induced by LPS in H9c2 cells.
- 4 September 2017
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 22 (1) , 19
Open AccessLuteolin, quercetin, genistein and quercetagetin inhibit the effects of lipopolysaccharide obtained from Porphyromonas gingivalis in H9c2 cardiomyoblasts
One of the microorganisms from dental plaque associated with severe inflammatory responses in infectious endocarditis is Porphyromonas gingivalis. It is a Gram-negative bacteria harvested from chronic periodontitis patients. Lipopolysaccharide (LPS) obtained from P. gingivalis promotes the expressions of interleukin-1 (IL-1), IL-6 and tumor necrosis factor alpha (TNF-α). Flavonoids are thought to participate in processes that control inflammation, such as the expression of cyclooxygenase-2 (COX-2). We investigated the effects of luteolin, quercetin, genistein and quercetagetin on cardiomyoblasts treated with LPS alone or in combination with following inhibitors p38 (SB203580), ERK (PD98059), JNK (SP600125) and PKC (Calphostin C) for 1 h. The kinase activation and COX-2 expression levels were determined at the gene and protein levels. These flavonoids are considered to inhibit the activation of mitogen-activated protein kinase (MAPK) and the degradation of inhibitor of kappa B-alpha (IκB-α). They also play a role in COX-2 expression. We conclude that the tested flavonoids inhibit inflammatory responses induced by LPS in H9c2 cells.
- Open Access
- 12 July 2016
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 25 (3) , 319-331
Biochemical and molecular modulation of CCl 4 -induced peripheral and central damage by Tilia americana var. mexicana extracts
Around the world, species from the genus Tilia are commonly used because of their peripheral and central medicinal effects; they are prepared as teas and used as tranquilizing, anticonvulsant, and analgesic agents. In this study, we provide evidence of the protective effects of organic and aqueous extracts (100 mg/kg, i.p.) obtained from the leaves of Tilia americana var. mexicana on CCl4-induced liver and brain damage in the rat. Protection was observed in the liver and brain (cerebellum, cortex and cerebral hemispheres) by measuring the activity of antioxidant enzymes and levels of malondialdehyde (MDA) using spectrophotometric methods. Biochemical parameters were also assessed in serum samples from the CCl4-treated rats. The T. americana var. mexicana leaf extracts provided significant protection against CCl4-induced peripheral and central damage by increasing the activity of antioxidant enzymes, diminishing lipid peroxidation, and preventing alterations in biochemical serum parameters, such as the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), γ-globulin (γ-GLOB), serum albumin (ALB), total bilirubin (BB), creatinine (CREA) and creatine kinase (CK), relative to the control group. Additionally, we correlated gene expression with antioxidant activity in the experimental groups treated with the organic and aqueous Tilia extracts and observed a non-statistically significant positive correlation. Our results provide evidence of the underlying biomedical properties of T. americana var. mexicana that confer its neuro- and hepatoprotective effects.
- 12 July 2016
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 25 (3) , 319-331
Open AccessBiochemical and molecular modulation of CCl 4 -induced peripheral and central damage by Tilia americana var. mexicana extracts
Around the world, species from the genus Tilia are commonly used because of their peripheral and central medicinal effects; they are prepared as teas and used as tranquilizing, anticonvulsant, and analgesic agents. In this study, we provide evidence of the protective effects of organic and aqueous extracts (100 mg/kg, i.p.) obtained from the leaves of Tilia americana var. mexicana on CCl4-induced liver and brain damage in the rat. Protection was observed in the liver and brain (cerebellum, cortex and cerebral hemispheres) by measuring the activity of antioxidant enzymes and levels of malondialdehyde (MDA) using spectrophotometric methods. Biochemical parameters were also assessed in serum samples from the CCl4-treated rats. The T. americana var. mexicana leaf extracts provided significant protection against CCl4-induced peripheral and central damage by increasing the activity of antioxidant enzymes, diminishing lipid peroxidation, and preventing alterations in biochemical serum parameters, such as the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), γ-globulin (γ-GLOB), serum albumin (ALB), total bilirubin (BB), creatinine (CREA) and creatine kinase (CK), relative to the control group. Additionally, we correlated gene expression with antioxidant activity in the experimental groups treated with the organic and aqueous Tilia extracts and observed a non-statistically significant positive correlation. Our results provide evidence of the underlying biomedical properties of T. americana var. mexicana that confer its neuro- and hepatoprotective effects.
- Open Access
- 23 June 2016
- Published by MedCrave Group Kft. in International Clinical Pathology Journal
- Vol. 4 (6) , 1-2
Studies of Infective Endocarditis in Cardiomyoblasts H9c2 Cell Line
- 23 June 2016
- Published by MedCrave Group Kft. in International Clinical Pathology Journal
- Vol. 4 (6) , 1-2
Open AccessStudies of Infective Endocarditis in Cardiomyoblasts H9c2 Cell Line
- Open Access
- 15 January 2016
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 68 (2) , 245-256
Curcumin prevents paracetamol-induced liver mitochondrial alterations
Objective: In the present study was evaluated if curcumin is able to attenuate paracetamol (PCM)-induced mitochondrial alterations in liver of mice. Methods: Mice (n = 5–6/group) received curcumin (35, 50 or 100 mg/kg bw) 90 min before PCM injection (350 mg/kg bw). Plasma activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) was measured; histological analyses were done; and measurement of mitochondrial oxygen consumption, mitochondrial membrane potential, ATP synthesis, aconitase activity and activity of respiratory complexes was carried out. Key findings: Curcumin prevented in a dose-dependent manner PCM-induced liver damage. Curcumin (100 mg/kg) attenuated PCM-induced liver histological damage (damaged hepatocytes from 28.3 ± 7.7 to 8.3 ± 0.7%) and increment in plasma ALT (from 2300 ± 150 to 690 ± 28 U/l) and AST (from 1603 ± 43 to 379 ± 22 U/l) activity. Moreover, curcumin attenuated the decrease in oxygen consumption using either succinate or malate/glutamate as substrates (evaluated by state 3, respiratory control ratio, uncoupled respiration and adenosine diphosphate/oxygen ratio), in membrane potential, in ATP synthesis, in aconitase activity and in the activity of respiratory complexes I, III and IV. Conclusions: These results indicate that the protective effect of curcumin in PCM-induced hepatotoxicity is associated with attenuation of mitochondrial dysfunction.
- 15 January 2016
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 68 (2) , 245-256
Open AccessCurcumin prevents paracetamol-induced liver mitochondrial alterations
Objective: In the present study was evaluated if curcumin is able to attenuate paracetamol (PCM)-induced mitochondrial alterations in liver of mice. Methods: Mice (n = 5–6/group) received curcumin (35, 50 or 100 mg/kg bw) 90 min before PCM injection (350 mg/kg bw). Plasma activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) was measured; histological analyses were done; and measurement of mitochondrial oxygen consumption, mitochondrial membrane potential, ATP synthesis, aconitase activity and activity of respiratory complexes was carried out. Key findings: Curcumin prevented in a dose-dependent manner PCM-induced liver damage. Curcumin (100 mg/kg) attenuated PCM-induced liver histological damage (damaged hepatocytes from 28.3 ± 7.7 to 8.3 ± 0.7%) and increment in plasma ALT (from 2300 ± 150 to 690 ± 28 U/l) and AST (from 1603 ± 43 to 379 ± 22 U/l) activity. Moreover, curcumin attenuated the decrease in oxygen consumption using either succinate or malate/glutamate as substrates (evaluated by state 3, respiratory control ratio, uncoupled respiration and adenosine diphosphate/oxygen ratio), in membrane potential, in ATP synthesis, in aconitase activity and in the activity of respiratory complexes I, III and IV. Conclusions: These results indicate that the protective effect of curcumin in PCM-induced hepatotoxicity is associated with attenuation of mitochondrial dysfunction.